The company expired its plan on November 4, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.65 EUR | +4.49% |
|
+3.75% | +5.70% |
04:07pm | Orion, Merck & Co. Convert Agreement into Exclusive Global License to Opevesostat | MT |
03:35pm | Orion Upgrades FY24 Outlook After Modifying Agreement with Merck & Co | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.70% | 5.99B | |
+56.08% | 815B | |
+43.42% | 641B | |
-5.50% | 352B | |
+17.89% | 314B | |
+11.24% | 303B | |
+16.75% | 242B | |
+2.49% | 224B | |
+14.19% | 218B | |
+9.69% | 168B |
- Stock Market
- Equities
- ORNBV Stock
- News Orion Oyj
- Orion Oyj's Equity Buyback announced on September 1, 2022, has expired.